AmerisourceBergen has announced its acquisition of the majority of Walgreens Boots Alliance’s Alliance Healthcare businesses.
AmerisourceBergen has announced its acquisition of the majority of Walgreens Boots Alliance’s Alliance Healthcare businesses, a move that will extend its core wholesale, distribution, and relation solutions capabilities globally.
Alliance Healthcare partners with health care companies and professionals to deliver a range of logistics and supply chain services and innovative solutions to help improve patient care. With advancing pharmaceutical innovation, global reach and specialty logistics is imperative, particularly for specialty medicines and cell and gene therapies.
According to AmerisourceBergen, the acquisition will “provide even stronger support for pharmacies and pharmacists across the globe and integrated solutions for pharmaceutical managers.” As such, with this acquisition Walgreens Boots Alliance will be able to increase its focus on expanding its core retail pharmacy businesses, the company said.
Furthermore, the acquisition will enhance AmerisourceBergen’s scale and margin profile, strengthening its platform to deliver continued growth across pharmaceutical distribution and manufacturer services.
“AmerisourceBergen’s vital role in the health system as a key pillar of pharmaceutical innovation and access has been on full display over the past year,” Steven Collis, chairman, president and chief executive officer of AmerisourceBergen, said in a statement. “AmerisourceBergen’s financial and strategic position enables this next evolution of enhancing our ability to provide healthcare capabilities across regions and deliver innovative solutions for our upstream and downstream partners.”
In addition to this transaction, the 2 companies have agreed to strengthen their strategic partnership by extending and expanding their commercial agreements. Their US distribution agreement will be extended by 3 years until 2029 and their partnership is being expanded to include a commitment to pursue additional opportunities in sourcing and distribution.
The transaction, which amounts to approximately $6.5 billion, is expected to close by AmerisourceBergen’s fiscal year-end 2021.
AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction. News release. AmerisourceBergen; January 6, 2021. Accessed January 7, 2021. https://investor.amerisourcebergen.com/news/news-details/2021/AmerisourceBergen-and-Walgreens-Boots-Alliance-Announce-Strategic-Transaction/default.aspx